These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32771304)

  • 1. Modeling the viral dynamics of SARS-CoV-2 infection.
    Wang S; Pan Y; Wang Q; Miao H; Brown AN; Rong L
    Math Biosci; 2020 Oct; 328():108438. PubMed ID: 32771304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Model for SARS-CoV-2 Infection with Treatment.
    Chatterjee AN; Al Basir F
    Comput Math Methods Med; 2020; 2020():1352982. PubMed ID: 32908574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
    Deng W; Bao L; Liu J; Xiao C; Liu J; Xue J; Lv Q; Qi F; Gao H; Yu P; Xu Y; Qu Y; Li F; Xiang Z; Yu H; Gong S; Liu M; Wang G; Wang S; Song Z; Liu Y; Zhao W; Han Y; Zhao L; Liu X; Wei Q; Qin C
    Science; 2020 Aug; 369(6505):818-823. PubMed ID: 32616673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.
    Singh KK; Chaubey G; Chen JY; Suravajhala P
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C258-C267. PubMed ID: 32510973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The within-host viral kinetics of SARS-CoV-2.
    Li CT; Xu JH; Liu JW; Zhou YC
    Math Biosci Eng; 2020 Mar; 17(4):2853-2861. PubMed ID: 32987502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell and animal models of SARS-CoV-2 pathogenesis and immunity.
    Leist SR; Schäfer A; Martinez DR
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32887790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of lethal human coronaviruses.
    Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
    Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
    Chandrashekar A; Liu J; Martinot AJ; McMahan K; Mercado NB; Peter L; Tostanoski LH; Yu J; Maliga Z; Nekorchuk M; Busman-Sahay K; Terry M; Wrijil LM; Ducat S; Martinez DR; Atyeo C; Fischinger S; Burke JS; Slein MD; Pessaint L; Van Ry A; Greenhouse J; Taylor T; Blade K; Cook A; Finneyfrock B; Brown R; Teow E; Velasco J; Zahn R; Wegmann F; Abbink P; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kordana N; Li Z; Lifton MA; Mahrokhian SH; Maxfield LF; Nityanandam R; Nkolola JP; Schmidt AG; Miller AD; Baric RS; Alter G; Sorger PK; Estes JD; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):812-817. PubMed ID: 32434946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
    Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
    Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
    Han M; Xu M; Zhang Y; Liu Z; Li S; He T; Li J; Gao Y; Liu W; Li T; Chen Z; Huang X; Cheng G; Wang J; Dittmer U; Witzke O; Zou G; Li X; Lu M; Zhang Z
    Med Microbiol Immunol; 2020 Dec; 209(6):657-668. PubMed ID: 32860073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
    Lieberman NAP; Peddu V; Xie H; Shrestha L; Huang ML; Mears MC; Cajimat MN; Bente DA; Shi PY; Bovier F; Roychoudhury P; Jerome KR; Moscona A; Porotto M; Greninger AL
    PLoS Biol; 2020 Sep; 18(9):e3000849. PubMed ID: 32898168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
    Shan C; Yao YF; Yang XL; Zhou YW; Gao G; Peng Y; Yang L; Hu X; Xiong J; Jiang RD; Zhang HJ; Gao XX; Peng C; Min J; Chen Y; Si HR; Wu J; Zhou P; Wang YY; Wei HP; Pang W; Hu ZF; Lv LB; Zheng YT; Shi ZL; Yuan ZM
    Cell Res; 2020 Aug; 30(8):670-677. PubMed ID: 32636454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between SARS-CoV-2 and the type I interferon response.
    Sa Ribero M; Jouvenet N; Dreux M; Nisole S
    PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological assessment of hospitalized patients with COVID-2019.
    Wölfel R; Corman VM; Guggemos W; Seilmaier M; Zange S; Müller MA; Niemeyer D; Jones TC; Vollmar P; Rothe C; Hoelscher M; Bleicker T; Brünink S; Schneider J; Ehmann R; Zwirglmaier K; Drosten C; Wendtner C
    Nature; 2020 May; 581(7809):465-469. PubMed ID: 32235945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of flavonoids against coronavirus infection.
    Russo M; Moccia S; Spagnuolo C; Tedesco I; Russo GL
    Chem Biol Interact; 2020 Sep; 328():109211. PubMed ID: 32735799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 20. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
    Arvin AM; Fink K; Schmid MA; Cathcart A; Spreafico R; Havenar-Daughton C; Lanzavecchia A; Corti D; Virgin HW
    Nature; 2020 Aug; 584(7821):353-363. PubMed ID: 32659783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.